<font size="-1" , face="Arial" ,"Helvetica">National Bipartisan Commission on the Future of Medicare

GO TO: Medicare HOME

Presented to the National Bipartisan Commission on the Future of Medicare
Commission Meeting / August 10, 1998 / Washington, D.C.

Testimony of Lynn Etheredge
                                   <font size="3" , face="Arial" ,"Helvetica">Member, National Academy of Social Insurance Panel
                                    on Fee-For-Service Medicare

          Mr. Etheredge's Bio. | Meeting Agenda 8/10/98

I. Introduction

A. For large private sector employers, purchasing strategies are producing the
     lowest rate of inflation in 35+ years;
B. Medicare has the potential to be highly successful in using purchasing tools
     as part of its management strategies for cost control, quality improvement,
     and customer service.

II. A New Strategy Is Needed
     A. Medicare’s tools are inadequate to deal with volume, quality, and cost
          issues in its fee-for-service program;
     B. After fifteen years, Medicare’s national price control system -- its major
          management tool -- has become a textbook example of  ‘‘regulatory
          capture’’, e.g.

1. inpatient services shifted; many small, inefficient providers with
    legislatively-protected payment rates; large and rising hospital
    DRG margins (15.9%, $10B+/year overpayment)

2. a mindset that accepts the industry’s current cost base + future 
    revenue   growth as a ‘‘given’’ -- and sees the job of politicians
    to be revenue-raisers for the industry or cut benefits.

III. Elements of A Purchasing Strategy

A. Medicare needs a bipartisan political consensus for a
     purchasing strategy so it can be run more like a business;

B. Purchasing should be used as a selective tool for large problems
     of excessive cost, poor quality and/or substandard service in
     specific geographic areas;

C. A purchasing strategy could be widely used, e.g.:

1) Centers of excellence, e.g. cancer; minimum
     standards for volume & outcomes for major
     procedures

2) Case management for high cost patients, e.g. dual
    Medicare-Medicaid eligibles (25%-30% of
    expenses for both programs)

3) Better programs for chronically ill, e.g. congestive       heart failure, chronic obstructive pulmonary
     disease, and terminally ill patients

4) Standard services and supplies (DME, lab, x-ray,
    outpatient surgery, home health)

5) New benefits, e.g. competitive bidding for Rx
    coverage from pharmacy benefit manager firms
    (PBMs)

6) DRGs and RBRVS were designed so they could
    be used  for health care purchasing

D. For providers, Medicare direct purchasing offers a strategy that
     will reward economy, high quality, and service and an
     alternative to being ‘‘down the food chain’’ from managed care
     companies

E. Medicare purchasing discretion needs effective political
    oversight

F. Medicare needs to learn from a new R&D strategy, best
    practices of private purchasers, public purchasers, and health
    plans

G. Related initiatives: cost-effectiveness and outcomes research,
     more HCFA resources and human capital investments, new
     contractors, decentralization, Medigap reforms


<font size="-1" , face="Arial" ,"Helvetica">Back to Top